General MedicationsINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSStandard
EPINEPHRINE
EPINEPHRINE
Standard Dose
1MG/ML (1MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview EPINEPHRINE is listed in Drugs@FDA under application 205029 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient EPINEPHRINE Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 1MG/ML (1MG/ML) Sponsor BPI LABS Submission history Latest submission status date: 2025-06-30 00:00:00.
Structured Monograph
Clinical summary
Approval overview EPINEPHRINE is listed in Drugs@FDA under application 205029 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient EPINEPHRINE Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 1MG/ML (1MG/ML) Sponsor BPI LABS Submission history Latest submission status date: 2025-06-30 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.